GlassScriptPhysician profile
John M Beal
NPI 1457329815
$2,561.06
in general payments reported to CMS, 2019-2025
25 companies · $409 in 2025
The $409 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $51.87 · 2021: $272 · 2022: $334 · 2023: $903 · 2024: $316 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,608 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,608.43 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $633.29 | 2021-2023 | Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $451.53 | 2023-2025 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $277.58 | 2019-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Omni Hysteroscope |
| Pfizer INC. | $261.31 | 2019-2025 | |
| Organon LLC | $143.53 | 2023-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $137.76 | 2021-2025 | |
| Millicent US INC | $114.42 | 2020-2025 | Intrarosa, Femring, Femlyv |
| Intuitive Surgical, INC. | $79.56 | 2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $55.47 | 2023 | Veozah |
| Innovation Technologies INC | $50.02 | 2023-2025 | Irrisept |
| Dexcom, INC. | $39.75 | 2025 | Dexcom G6 Transmitter |
| Roche Diagnostics Corporation | $39.14 | 2019 | |
| Merck Sharp & Dohme LLC | $37.34 | 2019 | |
| Minerva Surgical, INC | $35.92 | 2023 | |
| Allergan, INC. | $31.57 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $29.46 | 2022-2025 | Zurzuvae |
| Baxter Healthcare | $21.16 | 2025 | Perclot |
| Myovant Sciences INC. | $19.31 | 2022 | |
| Medtronic, INC. | $17.40 | 2023 | Truclear |
| Novo Nordisk INC | $16.81 | 2023 | Wegovy |
| Therapeuticsmd, INC. | $15.79 | 2022 | |
| Avion Pharmaceuticals | $14.81 | 2019 | |
| Exact Sciences Corporation | $13.71 | 2023 | Cologuard Collection Kit |
| Convatec INC. | $12.53 | 2022 | |
| Currax Pharmaceuticals LLC | $11.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Beal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.